If the FDA ‘mood’ is to ‘delay & stay in the grey zone’ with MSC cells….we can expect more hoops & micromanagement resulting in more fund raising via partnerships and/ CR and the dilution that comes with it. Yes it is a worst case scenario but until some news of substance is presented we’ll continue to inhale ‘hopium’ as required.
Gottlieb plus for Regen. Med., page-10
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.015(1.04%) |
Mkt cap ! $1.661B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $3.815M | 2.664M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11031 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 14844 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |